Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis
The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
Amyotrophic lateral sclerosis (ALS) is a degenerative disorder of motor neurons in the cortex, brainstem and spinal cord. Its cause is unknown and it is uniformly fatal, typically within five years. About 10% of cases are inherited as an autosomal dominant trait, with high penetrance after the sixth decade. In most instances, sporadic and autosomal dominant familial ALS (FALS) are clinically similar. We have previously shown that in some but not all FALS pedigrees the disease is linked to a genetic defect on chromosome 21q (refs 8, 9). Here we report tight genetic linkage between FALS and a gene that encodes a cytosolic, Cu/Zn-binding superoxide dismutase (SOD1), a homodimeric metalloenzyme that catalyzes the dismutation of the toxic superoxide anion O2.- to O2 and H2O2 (ref. 10). Given this linkage and the potential role of free radical toxicity in other neurodenegerative disorders, we investigated SOD1 as a candidate gene in FALS. We identified 11 different SOD1 missense mutations in 13 different FALS families.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Long-standing associations of some forms of ALS with mutations in genes coding for superoxide dismutase 1”
Citations
Cites
Beckman, J. S., Beckman, T. W., Chen, J., Marshall, P. A., & Freeman, B. A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.4.1620 · Cited by 7,029
Orita, M., Suzuki, Y., Sekiya, T., & Hayashi, K. (1989) · Genomics · doi:10.1016/0888-7543(89)90129-8 · Cited by 3,434
DNA damage and oxygen radical toxicity
Imlay, J. A., & Linn, S. (1988) · Science · doi:10.1126/science.3287616 · Cited by 1,974
Analysis of Human Genetic Linkage.
Edwards, A. W. F., & Ott, J. (1992) · Biometrics · doi:10.2307/2532370 · Cited by 1,691
Functional inactivation of genes by dominant negative mutations
Herskowitz, I. (1987) · Nature · doi:10.1038/329219a0 · Cited by 1,160
Carlioz, A., & Touati, D. (1986) · The EMBO Journal · doi:10.1002/j.1460-2075.1986.tb04256.x · Cited by 784
Centre d'Etude du polymorphisme humain (CEPH): Collaborative genetic mapping of the human genome
Dausset, J., Cann, H., Cohen, D., Lathrop, M., Lalouel, J.-M., & White, R. (1990) · Genomics · doi:10.1016/0888-7543(90)90491-c · Cited by 575
Copper,zinc superoxide dismutase is primarily a cytosolic protein in human cells.
Crapo, J. D., Oury, T., Rabouille, C., Slot, J. W., & Chang, L. Y. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.21.10405 · Cited by 503
Richardson, J., Thomas, K. A., Rubin, B. H., & Richardson, D. C. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.4.1349 · Cited by 403
Familial adult motor neuron disease: amyotrophic lateralsclerosis
(1986) · Neurology · doi:10.1212/wnl.36.4.511 · Cited by 401
Self-citation
Research works printed but not linked: 7
- Kurland, L. T. Proc. Staff Meet Mayo Clin. 32, 449–462 (1957).
- Swerts, L. & Van Den Bergh, R. J. J. genet. Hum. 24, 247–255 (1976).
- Fridovich, I. Adv. Enzym. 58, 61–97 (1986).
- Ott, J. Am. hum. Genet. 28, 528–529 (1976).
- Ott, J. Analysis of Human Genetics 203–216 (Johns Hopkins Univ. Press, Baltimore, 1991).
- Hallewell, R. A. et al. in Superoxide Dismutase in Chemistry, Biology and Medicine (ed. Rotilio, G.) 249–256 (Elsevier, 1986).
- Muller, H. in Sixth internat. Congr. Genetics (ed. Jones, D.) 213–255 (Brooklyn Botanic Gardens, Menasha, 1932).
Cited by
Items 1,001–1,100 of 1,128
The kynurenine pathway and inflammation in amyotrophic lateral sclerosis
Chen, Y., Stankovic, R., Cullen, K. M., Meininger, V., Garner, B., Coggan, S., Grant, R., Brew, B. J., & Guillemin, G. J. (2010) · Neurotoxicity Research · doi:10.1007/s12640-009-9129-7 · Cited by 141
“Subsequent intermediates include the neuroprotectants, kynurenic acid (KYNA), an N-methyl-D-aspartic (NMDA) receptor antagonist ( Perkins and Stone 1982 ) and picolinic acid (PIC) (Kalisch et al. 1994), a potent endogenous chelator, and the excitotoxin and NMDA receptor agonist, QUIN (Stone and Perkins 1981).”
BackgroundMahoney, D. J., Rodriguez, C., Devries, M., Yasuda, N., & Tarnopolsky, M. A. (2004) · Muscle & Nerve · doi:10.1002/mus.20004 · Cited by 140
Intercellular Spread of Protein Aggregates in Neurodegenerative Disease
Davis, A. A., Leyns, C. E. G., & Holtzman, D. M. (2018) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-100617-062636 · Cited by 131
“Mutations in SOD1 were originally linked to dominantly inherited forms of familial ALS, which account for approximately 10% or fewer of total disease cases (Rosen et al. 1993).”
BackgroundTakata, M., Tanaka, H., Kimura, M., Nagahara, Y., Tanaka, K., Kawasaki, K., Seto, M., Tsuruma, K., Shimazawa, M., & Hara, H. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12277 · Cited by 131
“Mutations of the gene coding for the enzyme copper– zinc superoxide dismutase 1 (SOD1) account for approximately 20% of the cases of fALS and represent a major known cause of the disease (Rosen et al., 1993).”
BackgroundThe gut microbiome: a key player in the complexity of amyotrophic lateral sclerosis (ALS)
Boddy, S. L., Giovannelli, I., Sassani, M., Cooper-Knock, J., Snyder, M. P., Segal, E., Elinav, E., Barker, L. A., Shaw, P. J., & McDermott, C. J. (2021) · BMC Medicine · doi:10.1186/s12916-020-01885-3 · Cited by 127
Neuroprotective efficacy of aminopropyl carbazoles in a mouse model of amyotrophic lateral sclerosis
Tesla, R., Wolf, H. P., Xu, P., Drawbridge, J., Estill, S. J., Huntington, P., McDaniel, L., Knobbe, W., Burket, A., Tran, S., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1213960109 · Cited by 129
Fisher, C. L., Cabelli, D. E., Tainer, J. A., Hallewell, R. A., & Getzoff, E. D. (1994) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.340190105 · Cited by 125
Béland, L.-C., Markovinovic, A., Jakovac, H., De Marchi, F., Bilic, E., Mazzini, L., Kriz, J., & Munitic, I. (2020) · Brain Communications · doi:10.1093/braincomms/fcaa124 · Cited by 125
“Since the discovery of the first ALS mutation in 1993 in superoxide dismutase 1 (SOD1), more than 50 different genes have been linked to ALS (Rosen et al., 1993; Renton et al., 2014; Brown and Al-Chalabi, 2017; Hardiman et al., 2017; Mejzini et al., 2019).”
BackgroundCox, G. A., Mahaffey, C. L., & Frankel, W. N. (1998) · Neuron · doi:10.1016/s0896-6273(00)80652-2 · Cited by 125
Troakes, C., Maekawa, S., Wijesekera, L., Rogelj, B., Siklós, L., Bell, C., Smith, B., Newhouse, S., Vance, C., Johnson, L., et al. (2012) · Neuropathology · doi:10.1111/j.1440-1789.2011.01286.x · Cited by 124
Neurotheranostics as Personalized Medicines
Kevadiya, B. D., Ottemann, B. M., Thomas, M. B., Mukadam, I., Nigam, S., McMillan, J., Gorantla, S., Bronich, T. K., Edagwa, B., & Gendelman, H. E. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.10.011 · Cited by 124
Chiot, A., Zaïdi, S., Iltis, C., Ribon, M., Berriat, F., Schiaffino, L., Jolly, A., de la Grange, P., Mallat, M., Bohl, D., et al. (2020) · Nature Neuroscience · doi:10.1038/s41593-020-00718-z · Cited by 122
Value of systematic genetic screening of patients with amyotrophic lateral sclerosis
Shepheard, S. R., Parker, M. D., Cooper-Knock, J., Verber, N. S., Tuddenham, L., Heath, P., Beauchamp, N., Place, E., Sollars, E. S. A., Turner, M. R., et al. (2021) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2020-325014 · Cited by 116
Mechanisms of Disease: DNA repair defects and neurological disease
Subba Rao, K. (2007) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro0448 · Cited by 121
Altered perivascular fibroblast activity precedes ALS disease onset
Månberg, A., Skene, N., Sanders, F., Trusohamn, M., Remnestål, J., Szczepińska, A., Aksoylu, I. S., Lönnerberg, P., Ebarasi, L., Wouters, S., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01295-9 · Cited by 120
Neuromuscular Junction Dismantling in Amyotrophic Lateral Sclerosis
Cappello, V., & Francolini, M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18102092 · Cited by 119
“In 1993, a landmark discovery of 11 missense mutations in the SOD1 gene, in 13 fALS families [47], heralded the genetic age for ALS.”
BackgroundGravel, M., Béland, L.-C., Soucy, G., Abdelhamid, E., Rahimian, R., Gravel, C., & Kriz, J. (2016) · The Journal of Neuroscience · doi:10.1523/jneurosci.0854-15.2016 · Cited by 117
“Approximately one-fifth of these familial cases are caused by mutations in superoxide dismutase 1 (SOD1; Rosen et al., 1993).”
BackgroundQuantification of reverse transcriptase in ALS and elimination of a novel retroviral candidate
McCormick, A. L., Brown, R. H., Cudkowicz, M. E., Al-Chalabi, A., & Garson, J. A. (2008) · Neurology · doi:10.1212/01.wnl.0000297552.13219.b4 · Cited by 117
Self-citationActivation of interferon signaling pathways in spinal cord astrocytes from an ALS mouse model
Wang, R., Yang, B., & Zhang, D. (2011) · Glia · doi:10.1002/glia.21167 · Cited by 115
Dysfunction of Optineurin in Amyotrophic Lateral Sclerosis and Glaucoma
Toth, R. P., & Atkin, J. D. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01017 · Cited by 114
“Furthermore, G93A SOD1 expressing microglia that are activated at the early stage of disease exhibit neuroprotective features that promote neuronal survival, whilst microglia from end stage animals display neurotoxic properties and induction of neuronal death (123).”
BackgroundInfluentialIncreased xanthine oxidase in the thalamus and putamen in depression
Michel, T. M., Camara, S., Tatschner, T., Frangou, S., Sheldrick, A. J., Riederer, P., & Grünblatt, E. (2010) · The World Journal of Biological Psychiatry · doi:10.3109/15622970802123695 · Cited by 114
“Oxidative stress (OS) has been implicated in the aetiology of various neurological conditions amongst which are Parkinson’s disease, Alzheimer’s dementia and amyotrophic lateral sclerosis, schizophrenia and lately depressive disorder (Saggu 1989; Riederer et al. 1992; Rosen et al. 1993; Durany et al. 1999; Grünblatt e…”
BackgroundSalminen, L. E., & Paul, R. H. (2014) · Reviews in the Neurosciences · doi:10.1515/revneuro-2014-0046 · Cited by 113
“Although abnormalities in SOD1 and SOD3 have been variably implicated in neuromuscular and cardiovascular conditions (Rosen et al., 1993; Fukai et al., 2002), manganese SOD (also referred to as SOD2) is likely most relevant to brain integrity due to localization within the mitochondrial matrix…”
BackgroundSteele, A. J., Al-Chalabi, A., Ferrante, K., Cudkowicz, M. E., Brown, R. H., & Garson, J. A. (2005) · Neurology · doi:10.1212/01.wnl.0000150899.76130.71 · Cited by 112
Self-citationAdvances in molecular pathology, diagnosis, and treatment of amyotrophic lateral sclerosis
Ilieva, H., Vullaganti, M., & Kwan, J. (2023) · BMJ · doi:10.1136/bmj-2023-075037 · Cited by 111
Natural Products as a Potential Modulator of Microglial Polarization in Neurodegenerative Diseases
Jin, X., Liu, M.-Y., Zhang, D.-F., Zhong, X., Du, K., Qian, P., Gao, H., & Wei, M.-J. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104253 · Cited by 109
Antisense drugs make sense for neurological diseases
Bennett, C. F., Kordasiewicz, H. B., & Cleveland, D. W. (2021) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010919-023738 · Cited by 108
“Mutations in the superoxide dismutase 1 (SOD1) gene was the first example of a gene that causes familial forms of ALS and accounts for approximately 20% of familial ALS cases (92).”
BackgroundWhat causes amyotrophic lateral sclerosis?
Martin, S., Al Khleifat, A., & Al-Chalabi, A. (2017) · F1000Research · doi:10.12688/f1000research.10476.1 · Cited by 107
Risk factors and emerging therapies in amyotrophic lateral sclerosis
Nowicka, N., Juranek, J., Juranek, J. K., & Wojtkiewicz, J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20112616 · Cited by 106
“was a mutation of the superoxide dismutase 1 (SOD1) gene [14].”
BackgroundSolomon, J. N., Lewis, C. B., Ajami, B., Corbel, S. Y., Rossi, F. M. V., & Krieger, C. (2006) · Glia · doi:10.1002/glia.20331 · Cited by 105
“ciated with mutations in the Cu/Zn superoxide dismutase (SOD1) gene (Rosen et al., 1993).”
BackgroundMitochondrial calcium cycling in neuronal function and neurodegeneration
Walters, G. C., & Usachev, Y. M. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1094356 · Cited by 105
“Although most cases of ALS occur sporadically, approximately 5–10% cases of ALS are familial, with mutations in the Cu/Zn superoxide dismutase (SOD1) gene accounting for approximately 20% of familial ALS cases (Rosen et al., 1993; Cook and Petrucelli, 2019).”
BackgroundThe role of the immune system in neurodegenerative disorders: Adaptive or maladaptive?
Doty, K. R., Guillot-Sestier, M.-V., & Town, T. (2015) · Brain Research · doi:10.1016/j.brainres.2014.09.008 · Cited by 104
Neuroinflammation in the Aging Down Syndrome Brain; Lessons from Alzheimer's Disease
Wilcock, D. M. (2012) · Current Gerontology and Geriatrics Research · doi:10.1155/2012/170276 · Cited by 104
“While the hypothesis for the role of these mutations centered on the potential loss of function, and, therefore, increased oxidative stress, there has been increasing evidence to discount this hypothesis including the lack of ALS symptoms or pathology in SOD1 knockout mice [91].”
BackgroundHarwood, C. A., McDermott, C. J., & Shaw, P. J. (2009) · Amyotrophic Lateral Sclerosis · doi:10.1080/17482960802549739 · Cited by 104
“A body of evidence now exists that strongly implicates oxidative stress as a significant contributory factor to motor neuron injury in MND, supported by dysfunction of the antioxidant enzyme, SOD1 in familial MND (24,77).”
BackgroundEvaluating the levels of interleukin-1 family cytokines in sporadic amyotrophic lateral sclerosis
Italiani, P., Carlesi, C., Giungato, P., Puxeddu, I., Borroni, B., Bossù, P., Migliorini, P., Siciliano, G., & Boraschi, D. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-94 · Cited by 103
“SOD1 mutations are the most common genetic cause of ALS in humans (accounting for 20% of familial ALS cases) [43], although in about 95% of ALS patients no genetic cause can be identified (sALS patients) [44].”
BackgroundReduction in frataxin causes progressive accumulation of mitochondrial damage
Karthikeyan, G. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg349 · Cited by 102
“For example, increased free radical production due to reduced SOD1/2 activity and complex1 defects have been implicated in amyotrophic lateral sclerosis (ALS) and Parkinson’s disease pathologies respectively (55).”
BackgroundPathogenic role of BECN1/Beclin 1 in the development of amyotrophic lateral sclerosis
Nassif, M., Valenzuela, V., Rojas-Rivera, D., Vidal, R., Matus, S., Castillo, K., Fuentealba, Y., Kroemer, G., Levine, B., & Hetz, C. (2014) · Autophagy · doi:10.4161/auto.28784 · Cited by 100
Development of Mitochondria‐targeted Aromatic‐cationic Peptides for Neurodegenerative Diseases
Szeto, H. H. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1427.013 · Cited by 100
Association of Cigarette Smoking with Amyotrophic Lateral Sclerosis
Kamel, F., Umbach, D. M., Munsat, T. L., Shefner, J. M., & Sandler, D. P. (1999) · Neuroepidemiology · doi:10.1159/000026211 · Cited by 100
Optineurin suppression causes neuronal cell death via NF‐κB pathway
Akizuki, M., Yamashita, H., Uemura, K., Maruyama, H., Kawakami, H., Ito, H., & Takahashi, R. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12326 · Cited by 96
Reactive Oxygen Species as Mediators of Photoreceptor Apoptosisin Vitro
Carmody, R. J., McGowan, A. J., & Cotter, T. G. (1999) · Experimental Cell Research · doi:10.1006/excr.1998.4421 · Cited by 98
CD44 expression in astrocytes and microglia is associated with ALS progression in a mouse model
Matsumoto, T., Imagama, S., Hirano, K., Ohgomori, T., Natori, T., Kobayashi, K., Muramoto, A., Ishiguro, N., & Kadomatsu, K. (2012) · Neuroscience Letters · doi:10.1016/j.neulet.2012.05.048 · Cited by 80
Antioxidant treatment for amyotrophic lateral sclerosis or motor neuron disease
Orrell, R. W., Lane, R. J., & Ross, M. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002829.pub4 · Cited by 98
Thau, N., Knippenberg, S., Körner, S., Rath, K. J., Dengler, R., & Petri, S. (2012) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e318275df4b · Cited by 97
“Quantification of spinal motoneuron loss in end-stage SOD1G93A mice resulted in 75% on average versus nontransgenic mice (Figure, Supplemental Digital Content 1, http://links.lww.com/NEN/A396).”
BackgroundBeyond muscles: The untapped potential of creatine
Riesberg, L. A., Weed, S. A., McDonald, T. L., Eckerson, J. M., & Drescher, K. M. (2016) · International Immunopharmacology · doi:10.1016/j.intimp.2015.12.034 · Cited by 95
Andreassen, O. A., Dedeoglu, A., Friedlich, A., Ferrante, K. L., Hughes, D., Szabo, C., & Beal, M. F. (2001) · Experimental Neurology · doi:10.1006/exnr.2001.7633 · Cited by 96
Harlan, B. A., Pehar, M., Sharma, D. R., Beeson, G., Beeson, C. C., & Vargas, M. R. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.698779 · Cited by 94
“About 5–10% of the cases are inherited (familial ALS (FALS)), and the first ALS-linked gene identifiedwas superoxide dismutase 1 (SOD1) (32).”
BackgroundMolecular targets of non-steroidal anti-inflammatory drugs in neurodegenerative diseases
Lleo, A., Galea, E., & Sastre, M. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-6516-1 · Cited by 93
Moisse, K., Mepham, J., Volkening, K., Welch, I., Hill, T., & Strong, M. J. (2009) · Brain Research · doi:10.1016/j.brainres.2009.07.023 · Cited by 93
“. the pathogenesis of ALS (Rosen et al., 1993; Strong, 1999; Schaefer et al., 2005; Strong et al., 2005; Moisse and Strong, 2006).”
BackgroundMoulard, B., Sefiani, A., Laamri, A., Malafosse, A., & Camu, W. (1996) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(96)00085-8 · Cited by 93
Biomarkers in Neurodegenerative Diseases
Jeromin, A., & Bowser, R. (2017) · Advances in Neurobiology · doi:10.1007/978-3-319-57193-5_20 · Cited by 92
Fitzgerald, K. C., O'Reilly, É. J., Fondell, E., Falcone, G. J., McCullough, M. L., Park, Y., Kolonel, L. N., & Ascherio, A. (2013) · Annals of Neurology · doi:10.1002/ana.23820 · Cited by 91
Brain modulation by the gut microbiota: From disease to therapy
Mitra, S., Dash, R., Nishan, A. A., Habiba, S. U., & Moon, I. S. (2023) · Journal of Advanced Research · doi:10.1016/j.jare.2022.12.001 · Cited by 91
“Several studies have found evidence that ALS is caused by genetic mutations (similar to those in C9ORF72 and SOD1) [153–156].”
BackgroundFailure of protein quality control in amyotrophic lateral sclerosis
Kabashi, E., & Durham, H. D. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2006.06.006 · Cited by 90
Genetics of Amyotrophic Lateral Sclerosis
Gregory, J. M., Fagegaltier, D., Phatnani, H., & Harms, M. B. (2020) · Current Genetic Medicine Reports · doi:10.1007/s40142-020-00194-8 · Cited by 83
Proteomics Approaches for Biomarker and Drug Target Discovery in ALS and FTD
Hedl, T. J., San Gil, R., Cheng, F., Rayner, S. L., Davidson, J. M., De Luca, A., Villalva, M. D., Ecroyd, H., Walker, A. K., & Lee, A. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00548 · Cited by 87
Storr, H. L., Kind, B., Parfitt, D. A., Chapple, J. P., Lorenz, M., Koehler, K., Huebner, A., & Clark, A. J. L. (2009) · Molecular Endocrinology · doi:10.1210/me.2009-0056 · Cited by 84
Pearson, J. P., Williams, N. M., Majounie, E., Waite, A., Stott, J., Newsway, V., Murray, A., Hernandez, D., Guerreiro, R., Singleton, A. B., et al. (2011) · Journal of Neurology · doi:10.1007/s00415-010-5815-x · Cited by 84
“Causative mutations for familial ALS have been identified in the SOD-1 [22] and FUS [23] genes, but in these families the pathology is distinct from sporadic ALS.”
Eitan, E., Tichon, A., Gazit, A., Gitler, D., Slavin, S., & Priel, E. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201200212 · Cited by 82
“Mutations in the Cu/Zn Superoxide Dismutase 1 gene (SOD1) account for (cid:1) 20% of familial ALS (fALS) cases, corresponding to 2–3% of all ALS cases (Rosen, 1993).”
Modeling cell-autonomous motor neuron phenotypes in ALS using iPSCs
Hawrot, J., Imhof, S., & Wainger, B. J. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104680 · Cited by 74
Tanji, K., Maruyama, A., Odagiri, S., Mori, F., Itoh, K., Kakita, A., Takahashi, H., & Wakabayashi, K. (2013) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31827b5713 · Cited by 80
Gomes, C., Cunha, C., Nascimento, F., Ribeiro, J. A., Vaz, A. R., & Brites, D. (2019) · Molecular Neurobiology · doi:10.1007/s12035-018-1220-8 · Cited by 79
“Mutations in the antioxidant enzyme Cu/Zn superoxide dismutase-1 (SOD1) gene was the first genetic link discovered in ALS [2] and account for 20–25% of fALS cases [3].”
BackgroundApolipoprotein E is associated with age at onset of amyotrophic lateral sclerosis
Li, Y.-J., Pericak-Vance, M. A., Haines, J. L., Siddique, N., McKenna-Yasek, D., Hung, W.-Y., Sapp, P., Allen, C. I., Chen, W., Hosler, B., et al. (2004) · Neurogenetics · doi:10.1007/s10048-004-0193-0 · Cited by 77
“Approximately 25% of autosomal dominant ALS is caused by mutations in the Cu/Zn superoxide dismutase (SOD1) gene [1, 2].”
BackgroundSelf-citationStieber, A., Gonatas, J. O., & Gonatas, N. K. (2000) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(00)00351-8 · Cited by 76
Mitochondria and endoplasmic reticulum crosstalk in amyotrophic lateral sclerosis
Manfredi, G., & Kawamata, H. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.08.004 · Cited by 76
Basal lamina changes in neurodegenerative disorders
Nguyen, B., Bix, G., & Yao, Y. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00502-y · Cited by 75
“On one hand, increased collagen IV is observed in the spinal cords of SOD1G93A mice at 18 weeks of age [45].”
BackgroundInfluentialUrushitani, M., Ezzi, S. A., Matsuo, A., Tooyama, I., & Julien, J.-P. (2008) · The FASEB Journal · doi:10.1096/fj.07-092783 · Cited by 75
ALS and frontotemporal dysfunction: a review
Achi, E. Y., & Rudnicki, S. A. (2012) · Neurology Research International · doi:10.1155/2012/806306 · Cited by 74
Rising Stars: Astrocytes as a Therapeutic Target for ALS Disease
Izrael, M., Slutsky, S. G., & Revel, M. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00824 · Cited by 73
“Familial ALS (fALS) includes mutations of Cu/Zn superoxide dismutase (Rosen, 1993), TAR-DNA-binding protein of 43 kDa (Neumann et al., 2006), fused in sarcoma (Fus) (Kwiatkowski et al., 2009; Vance et al., 2009) and amplification of hexanucleotide (GGGGCC) repeat expansions in the chromosome 9 open…”
BackgroundImplications of Microglia in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
Haukedal, H., & Freude, K. (2019) · Journal of Molecular Biology · doi:10.1016/j.jmb.2019.02.004 · Cited by 68
Seilhean, D., Cazeneuve, C., Thuriès, V., Russaouen, O., Millecamps, S., Salachas, F., Meininger, V., LeGuern, E., & Duyckaerts, C. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0545-9 · Cited by 71
“mutations of the Cu/Zn superoxide dismutase-1 (SOD1) gene encoding an antioxidant enzyme [50].”
BackgroundAn increase of oxidized coenzyme Q-10 occurs in the plasma of sporadic ALS patients
Sohmiya, M., Tanaka, M., Suzuki, Y., Tanino, Y., Okamoto, K., & Yamamoto, Y. (2005) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2004.09.030 · Cited by 69
“Oxidative stress has been suggested to underlie pathogenesis of ALS inasmuch as missense point mutations occur in the copper/zinc (Cu/Zn) superoxide dismutase (SOD) gene of familial ALS patients [1,2].”
BackgroundGenetics of amyotrophic lateral sclerosis
Corcia, P., Couratier, P., Blasco, H., Andres, C. R., Beltran, S., Meininger, V., & Vourc’h, P. (2017) · Revue Neurologique · doi:10.1016/j.neurol.2017.03.030 · Cited by 68
Deng, H.-X. (2011) · Archives of Neurology · doi:10.1001/archneurol.2011.178 · Cited by 67
“Genetic mutations in the Cu/Zn superoxide dismutase gene, SOD1, are the most frequent cause of ALS, accounting for approximately 20% of FALS and 1% of SALS cases.(1,2) An additional 8% to 10% of FALS is accounted for by mutations in the TDP43 and FUS genes.”
BackgroundSelf-citationRetromer stabilization results in neuroprotection in a model of Amyotrophic Lateral Sclerosis
Muzio, L., Sirtori, R., Gornati, D., Eleuteri, S., Fossaghi, A., Brancaccio, D., Manzoni, L., Ottoboni, L., Feo, L. D., Quattrini, A., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17524-7 · Cited by 65
Kim, H. J., Magranè, J., Starkov, A. A., & Manfredi, G. (2012) · Brain · doi:10.1093/brain/aws208 · Cited by 64
“CuZn superoxide dismutase (SOD1) (Rosen et al., 1993), which cause a toxic gain of function of the protein (Gurney et al.”
BackgroundHuang, M., Liu, Y. U., Yao, X., Qin, D., & Su, H. (2024) · Translational Neurodegeneration · doi:10.1186/s40035-024-00416-x · Cited by 64
Huang, Q., Wang, Y., Chen, S., & Liang, F. (2023) · Aging and disease · doi:10.14336/ad.2023.0807 · Cited by 62
“Research on adult family lineages has identified specific gene mutations, including SOD1, C9orf72, TDP43, and FUS74, which are associated with the heritability of ALS [112, 113].”
BackgroundMass spectrometric analysis of protein tyrosine nitration in aging and neurodegenerative diseases
Yeo, W., Kim, Y. J., Kabir, M. H., Kang, J. W., & Kim, K. P. (2015) · Mass Spectrometry Reviews · doi:10.1002/mas.21429 · Cited by 61
Mayer, J., Harz, C., Sanchez, L., Pereira, G. C., Maldener, E., Heras, S. R., Ostrow, L. W., Ravits, J., Batra, R., Meese, E., et al. (2018) · Molecular Neurodegeneration · doi:10.1186/s13024-018-0275-3 · Cited by 60
Amyotrophic lateral sclerosis pathogenesis: a journey through the secretory pathway
Nassif, M., Matus, S., Castillo, K., & Hetz, C. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2991 · Cited by 60
Zhang, H., Andrekopoulos, C., Joseph, J., Crow, J., & Kalyanaraman, B. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.02.038 · Cited by 59
Dutta, K., Patel, P., & Julien, J.-P. (2018) · Experimental Neurology · doi:10.1016/j.expneurol.2018.08.008 · Cited by 56
“oxide dismutase (or SOD1) were the first to be discovered as causative of ALS (Rosen et al., 1993).”
Background11 C‐PK11195 PET–based molecular study of microglia activation in SOD1 amyotrophic lateral sclerosis
Tondo, G., Iaccarino, L., Cerami, C., Vanoli, G. E., Presotto, L., Masiello, V., Coliva, A., Salvi, F., Bartolomei, I., Mosca, L., et al. (2020) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51112 · Cited by 56
USP7 regulates ALS-associated proteotoxicity and quality control through the NEDD4L–SMAD pathway
Zhang, T., Periz, G., Lu, Y.-N., & Wang, J. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2014349117 · Cited by 55
Gowing, G., Lalancette-Hébert, M., Audet, J.-N., Dequen, F., & Julien, J.-P. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.08.021 · Cited by 53
Schulz, J. B., Cookson, M. R., & Hausmann, L. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13844 · Cited by 52
Harlan, B. A., Pehar, M., Killoy, K. M., & Vargas, M. R. (2019) · The FASEB Journal · doi:10.1096/fj.201802752r · Cited by 50
“identified was superoxide dismutase 1 (SOD1) (2).”
Yamadera, M., Fujimura, H., Inoue, K., Toyooka, K., Mori, C., Hirano, H., & Sakoda, S. (2015) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2015.1011663 · Cited by 49
Biomarker discovery and development for frontotemporal dementia and amyotrophic lateral sclerosis
Katzeff, J. S., Bright, F., Phan, K., Kril, J. J., Ittner, L. M., Kassiou, M., Hodges, J. R., Piguet, O., Kiernan, M. C., Halliday, G. M., et al. (2022) · Brain · doi:10.1093/brain/awac077 · Cited by 48
“There are numerous amyotrophic lateral sclerosis-linked SOD1 mutations.(59,60) SOD1 protein aggregates are characteristic of amyotrophic lateral sclerosis patients”
BackgroundGünther, R., Balck, A., Koch, J. C., Nientiedt, T., Sereda, M., Bähr, M., Lingor, P., & Tönges, L. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00017 · Cited by 47
“While genetic mutations in the human superoxide dismutase 1 (SOD1) were the first to be identified (Rosen et al., 1993), further pathogenic mutations have also been found in Fused in sarcoma (FUS), TAR DNA-binding protein 43 (TDP-43), or in the gene C9orf72 (Turner et al.”
Rho GTPases in neurodegeneration diseases
DeGeer, J., & Lamarche-Vane, N. (2013) · Experimental Cell Research · doi:10.1016/j.yexcr.2013.06.016 · Cited by 46
Binazzi, A., Belli, S., Uccelli, R., Desiato, M. T., Talamanca, I. F., Antonini, G., Corsi, F., Scoppetta, C., Inghilleri, M., Pontieri, F., et al. (2008) · Amyotrophic Lateral Sclerosis · doi:10.1080/17482960802382313 · Cited by 46
The role of soluble intercellular adhesion molecules in neurodegenerative disorders
Rentzos, M., Michalopoulou, M., Nikolaou, C., Cambouri, C., Rombos, A., Dimitrakopoulos, A., & Vassilopoulos, D. (2005) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2004.11.001 · Cited by 45
“Genetic factors have been implicated in familial ALS, 5% of all ALS cases [17].”
BackgroundLi, C., Chen, Y., Chen, X., Wei, Q., Cao, B., & Shang, H. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00160 · Cited by 45
“Several causative genes including chromosome 9 open reading frame 72 (C9orf72, DeJesus-Hernandez et al., 2011), Cu/Zn-superoxide dismutase (SOD1; Rosen et al., 1993), TAR DNA-binding protein (TARDBP) which encodes TDP43 (Sreedharan et al., 2008), and fused in sarcoma (FUS; Vance et al., 2009) have…”
BackgroundSun, J., Mu, Y., Jiang, Y., Song, R., Yi, J., Zhou, J., Sun, J., Jiao, X., Prinz, R. A., Li, Y., et al. (2018) · Cell Death & Disease · doi:10.1038/s41419-018-0441-0 · Cited by 44
UBQLN2 mutations are rare in French and French–Canadian amyotrophic lateral sclerosis
Daoud, H., Suhail, H., Szuto, A., Camu, W., Salachas, F., Meininger, V., Bouchard, J.-P., Dupré, N., Dion, P. A., & Rouleau, G. A. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.03.015 · Cited by 42
“Several genes have been implicated in familial and sporadic ALS, among which SOD1 (Superoxide dismutase 1) (Rosen et al., 1993), TARDBP (TAR DNA-binding protein) (Kabashi et al., 2008), and FUS (Fused in Sarcoma) (Vance et al., 2009) genes are the most frequent causative genes.”
Self-citationGut microbiome and amyotrophic lateral sclerosis: a systematic review of current evidence
Sun, J., Huang, T., Debelius, J. W., & Fang, F. (2021) · Journal of Internal Medicine · doi:10.1111/joim.13336 · Cited by 43
Stieber, A., Gonatas, J. O., Moore, J. S., Bantly, A., Yim, H.-S., Yim, M. B., & Gonatas, N. K. (2004) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2003.12.004 · Cited by 38
Approaches to gene modulation therapy for ALS
Meijboom, K. E., & Brown, R. H. (2022) · Neurotherapeutics · doi:10.1007/s13311-022-01285-w · Cited by 38
“The first ALS-associated gene, superoxide dismutase-1 (SOD1), was identified in 1993 [18].”
BackgroundSelf-citationHong, D., Zhang, C., Wu, W., Lu, X., & Zhang, L. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1133546 · Cited by 38
Metadata
- Authors
- Rosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J. P., Deng, H.-X., Rahmani, Z., Krizus, A., McKenna-Yasek, D., Cayabyab, A., Gaston, S. M., Berger, R., Tanzi, R. E., Halperin, J. J., Herzfeldt, B., Van den Bergh, R., Hung, W.-Y., Bird, T., Deng, G., Mulder, D. W., Smyth, C., Laing, N. G., Soriano, E., Pericak–Vance, M. A., Haines, J., Rouleau, G. A., Gusella, J. S., Horvitz, H. R., & Brown, R. H.
- Affiliations
- Massachusetts General Hospital (US)
- Northwestern University (US)
- Montreal General Hospital (CA)
- Howard Hughes Medical Institute (US)
- North Shore University Hospital (US)
- University of Washington (US)
- Mayo Clinic (US)
- ORCID
- Venue
- Nature
- Published
- 1993-03-01
- Volume
- 362
- Issue
- 6415
- Pages
- 59-62
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2096386031
- Cited by
- 7,062
- References
- 42
- Citations by year
- 2026: 137 · 2025: 154 · 2024: 201 · 2023: 185 · 2022: 254 · 2021: 259 · 2020: 295 · 2019: 205 · 2018: 258 · 2017: 248 · 2016: 242 · 2015: 248 · 2014: 262 · 2013: 264 · 2012: 315
- FWCI
- 174.77
- Type
- journal article
- Language
- en
- Update notices
- correction (1993-07-22)
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glutathione Transferases and Polymorphisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
- Keywords
- amyotrophic lateral sclerosis, familial ALS, SOD1, Cu/Zn superoxide dismutase, missense mutations, genetic linkage, chromosome 21q, autosomal dominant inheritance, free radical toxicity, candidate genes, motor neuron degeneration
- MeSH terms
- Amino Acid Sequence, Amyotrophic Lateral Sclerosis, Animals, Base Sequence, Codon, DNA, Exons, Humans, Isoenzymes, Lod Score, Molecular Sequence Data, Mutation, Nucleic Acid Conformation, Oligodeoxyribonucleotides, Polymorphism, Genetic, Repetitive Sequences, Nucleic Acid, Superoxide Dismutase, Genome, Human, Polymerase Chain Reaction, Sequence Homology, Amino Acid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.